Wordt geladen...
Implementing genotype-guided antithrombotic therapy
Genotyping has the potential to improve the efficacy and safety of major antithrombotic drugs. For warfarin, the stable maintenance dose varies from 1–10 mg/day. The VKORC1 −1639G>A allele and the CYP2C9*2 and *3 alleles (cumulative frequency: 90% in Asians, 65% in Europeans and 20% in Africans),...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2903229/ https://ncbi.nlm.nih.gov/pubmed/20462345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fca.10.6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|